Full Text
PHP131 How Can Pharma Industry Prepare Itself for the Changing Pricing and Reimbursement Landscape of Orphan Drugs in EU?

Abstract

Authors

S. Mukku F. Pang D. Mcconkey

Back to Volume 14, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×